SNT 0.00% 3.5¢ syntara limited

Looks like the price is creeping up again.Phase 3 CF trial...

  1. 772 Posts.
    lightbulb Created with Sketch. 165
    Looks like the price is creeping up again.

    Phase 3 CF trial results due out within next 3 months.

    Positive result shoudl allowing marketing applications in Aust & Europe.

    Market size Aust&Europe 45,000 patients

    Potential take up 20% = 9,000 patients

    Revenue per patient approx $13,000 (est by PXS on investor calls)

    Revenue per annum potential $117m

    This does not include potential US sales later
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.5¢
Change
0.000(0.00%)
Mkt cap ! $45.16M
Open High Low Value Volume
3.5¢ 3.6¢ 3.5¢ $27.92K 778.4K

Buyers (Bids)

No. Vol. Price($)
2 853533 3.5¢
 

Sellers (Offers)

Price($) Vol. No.
3.6¢ 286037 1
View Market Depth
Last trade - 15.57pm 28/08/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.